Skip to main content
Signal8

Mineo Chrysa

SEC insider (Form 3/4/5 filer). CIK 0001575644. Director at Cidara Therapeutics, Inc. (CDTX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SAN DIEGO, CA.

Companies Mineo Chrysa has filed insider reports for

  • Cidara Therapeutics, Inc. (CDTX): Director
Mineo Chrysa profile photo

Mineo Chrysa

CIK: 0001575644

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cidara Therapeutics, Inc. logo
CDTX

Cidara Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Jan 7, 2026
    Disposition
    Direct
    3.3K shares at avg. $221.50$735K
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Jun 18, 2025
    Award

    Stock Option (right to buy)

    Direct
    11.1K shares-
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Jun 3, 2025
    Purchase
    Direct
    1.1K shares at avg. $23.44$25K
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Jun 2, 2025
    Purchase
    Direct
    2.3K shares at avg. $21.71$49K
  • Cidara Therapeutics, Inc. logo
    CDTX

    Cidara Therapeutics, Inc.

    Dec 17, 2024
    Award

    Stock Option (right to buy)

    Direct
    19K shares-

1-5 of 5